Approval · Notice of Compliance 4651 · 1996
VENTOLIN: Notice of Compliance 4651
Issued March 7, 1996
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4651
- Date
- March 7, 1996
- Company
- Glaxo Wellcome Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Bronchodilator, beta2-adrenergic stimulant
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VENTOLIN | 02212315 | Cancelled Post Market |
| VENTOLIN | 02212323 | Cancelled Post Market |
| VENTOLIN | 02212390 | Cancelled Post Market |
| VENTOLIN | 02213427 | Cancelled Post Market |
| VENTOLIN | 02213419 | Cancelled Post Market |
| VENTOLIN | 02213400 | Cancelled Post Market |
| VENTOLIN | 02213478 | Cancelled Post Market |
| VENTOLIN | 02213486 | Marketed |
| VENTOLIN | 02213435 | Cancelled Post Market |
| VENTOLIN | 02213443 | Cancelled Post Market |
| VENTOLIN | 02213451 | Marketed |
Medicinal ingredients
- SALBUTAMOL SULFATE 200 MCG per CAP
- SALBUTAMOL SULFATE 400 MCG per CAP
- SALBUTAMOL SULFATE 0.4 MG per ML
- SALBUTAMOL SULFATE 5 MG per 2.5ML
- SALBUTAMOL SULFATE 2.5 MG per 2.5ML
- SALBUTAMOL SULFATE 1.25 MG per 2.5ML
- SALBUTAMOL SULFATE 100 MCG per ACT
- SALBUTAMOL SULFATE 5 MG per ML
- SALBUTAMOL SULFATE 0.05 MG per ML
- SALBUTAMOL SULFATE 0.5 MG per ML
- SALBUTAMOL SULFATE 1 MG per ML